Large-scale testing (Phase 3)Active Not RecruitingNCT04437511
What this trial is testing
Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Who this might be right for
Alzheimer Disease
Eli Lilly and Company 1,736